Financial statements Bio Plus
Balance sheet data of BIO PLUS
Year
|
2019
|
2021
|
2022
|
2023
|
---|---|---|---|---|
Total assets | 158 676,29 | 206 747,20 | 356 265,12 | 691 981,95 |
A. Fixed assets | 42 525,00 | 27 675,00 | 12 825,00 | 0,00 |
B. Current assets | 116 151,29 | 179 072,20 | 343 440,12 | 691 981,95 |
C. Share capital contributions (basic funds) | - | - | - | - |
D. Own shares (stocks) | - | - | - | - |
Total liabilities | 158 676,29 | 206 747,20 | 356 265,12 | 691 981,95 |
A. Equity | 62 952,05 | -72 358,33 | -214 913,63 | -75 605,51 |
B. Liabilities and provisions for liabilities | 95 724,24 | 279 105,53 | 571 178,75 | 767 587,46 |
I. Long-term liabilities | 0,00 | 0,00 | 81 731,04 | 205 300,00 |
II. Short-term liabilities | 46 199,24 | 233 930,53 | 342 722,71 | 562 287,46 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.